Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Allarity Therapeutics (ALLR) Consolidated Net Income (2024 - 2025)

Allarity Therapeutics' Consolidated Net Income history spans 2 years, with the latest figure at $2.3 million for Q4 2025.

  • For Q4 2025, Consolidated Net Income fell 74.27% year-over-year to $2.3 million; the TTM value through Dec 2025 reached -$5.5 million, up 32.06%, while the annual FY2025 figure was -$5.6 million, 31.66% up from the prior year.
  • Consolidated Net Income reached $2.3 million in Q4 2025 per ALLR's latest filing, up from -$2.8 million in the prior quarter.
  • In the past five years, Consolidated Net Income ranged from a high of $8.9 million in Q4 2024 to a low of -$11.6 million in Q3 2024.